This research report provides a comprehensive analysis of the Pasireotide Drugs market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Pasireotide Drugs market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Pasireotide Drugs, challenges faced by the industry, and potential opportunities for market players.
The global Pasireotide Drugs market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Pasireotide Drugs market presents opportunities for various stakeholders, including Hospital, Pharmacy. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Pasireotide Drugs market. Additionally, the growing consumer demand present avenues for market expansion.
The global Pasireotide Drugs market was valued at US$ 98.6 million in 2023 and is projected to reach US$ 118.8 million by 2030, at a CAGR of 2.6% during the forecast period.
Pasireotide is a somatostatin analog used to treat Cushing's disease and acromegaly. Its effectiveness in controlling hormone overproduction has driven market growth. The rising prevalence of these conditions, coupled with the drug's extended receptor binding profile, contributes to its popularity. However, limited clinical data and the need for individualized treatment plans may pose challenges. The market competition is relatively small compared to other treatment options. Despite challenges, the Pasireotide market offers potential for expansion as healthcare providers seek effective therapies for patients with Cushing's disease and acromegaly. Further research and strategic marketing efforts can drive market growth in the future.
Key Features:
The research report on the Pasireotide Drugs market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Pasireotide Drugs market.
Market Overview: The report provides a comprehensive overview of the Pasireotide Drugs market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., 0.3mg/ml, 0.6mg/ml), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Pasireotide Drugs market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Pasireotide Drugs market's trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Pasireotide Drugs market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Pasireotide Drugs market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Pasireotide Drugs market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Pasireotide Drugs market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Pasireotide Drugs, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Pasireotide Drugs market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
- Pasireotide Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- 0.3mg/ml
- 0.6mg/ml
- 0.9mg/ml
Market segment by Application
Global Pasireotide Drugs Market Segment Percentages, By Region and Country, 2023 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Major players covered
Outline of Major Chapters:
Chapter 1: Introduces the definition of Pasireotide Drugs, market overview.
Chapter 2: Global Pasireotide Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Pasireotide Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments
by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments
by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Pasireotide Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Pasireotide Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Pasireotide Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Pasireotide Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Pasireotide Drugs Overall Market Size
2.1 Global Pasireotide Drugs Market Size: 2023 VS 2030
2.2 Global Pasireotide Drugs Revenue, Prospects & Forecasts: 2019-2030
2.3 Global Pasireotide Drugs Sales: 2019-2030
3 Company Landscape
3.1 Top Pasireotide Drugs Players in Global Market
3.2 Top Global Pasireotide Drugs Companies Ranked by Revenue
3.3 Global Pasireotide Drugs Revenue by Companies
3.4 Global Pasireotide Drugs Sales by Companies
3.5 Global Pasireotide Drugs Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Pasireotide Drugs Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers Pasireotide Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Pasireotide Drugs Players in Global Market
3.8.1 List of Global Tier 1 Pasireotide Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Pasireotide Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Pasireotide Drugs Market Size Markets, 2023 & 2030
4.1.2 0.3mg/ml
4.1.3 0.6mg/ml
4.1.4 0.9mg/ml
4.2 By Type - Global Pasireotide Drugs Revenue & Forecasts
4.2.1 By Type - Global Pasireotide Drugs Revenue, 2019-2024
4.2.2 By Type - Global Pasireotide Drugs Revenue, 2025-2030
4.2.3 By Type - Global Pasireotide Drugs Revenue Market Share, 2019-2030
4.3 By Type - Global Pasireotide Drugs Sales & Forecasts
4.3.1 By Type - Global Pasireotide Drugs Sales, 2019-2024
4.3.2 By Type - Global Pasireotide Drugs Sales, 2025-2030
4.3.3 By Type - Global Pasireotide Drugs Sales Market Share, 2019-2030
4.4 By Type - Global Pasireotide Drugs Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Pasireotide Drugs Market Size, 2023 & 2030
5.1.2 Hospital
5.1.3 Pharmacy
5.2 By Application - Global Pasireotide Drugs Revenue & Forecasts
5.2.1 By Application - Global Pasireotide Drugs Revenue, 2019-2024
5.2.2 By Application - Global Pasireotide Drugs Revenue, 2025-2030
5.2.3 By Application - Global Pasireotide Drugs Revenue Market Share, 2019-2030
5.3 By Application - Global Pasireotide Drugs Sales & Forecasts
5.3.1 By Application - Global Pasireotide Drugs Sales, 2019-2024
5.3.2 By Application - Global Pasireotide Drugs Sales, 2025-2030
5.3.3 By Application - Global Pasireotide Drugs Sales Market Share, 2019-2030
5.4 By Application - Global Pasireotide Drugs Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global Pasireotide Drugs Market Size, 2023 & 2030
6.2 By Region - Global Pasireotide Drugs Revenue & Forecasts
6.2.1 By Region - Global Pasireotide Drugs Revenue, 2019-2024
6.2.2 By Region - Global Pasireotide Drugs Revenue, 2025-2030
6.2.3 By Region - Global Pasireotide Drugs Revenue Market Share, 2019-2030
6.3 By Region - Global Pasireotide Drugs Sales & Forecasts
6.3.1 By Region - Global Pasireotide Drugs Sales, 2019-2024
6.3.2 By Region - Global Pasireotide Drugs Sales, 2025-2030
6.3.3 By Region - Global Pasireotide Drugs Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America Pasireotide Drugs Revenue, 2019-2030
6.4.2 By Country - North America Pasireotide Drugs Sales, 2019-2030
6.4.3 US Pasireotide Drugs Market Size, 2019-2030
6.4.4 Canada Pasireotide Drugs Market Size, 2019-2030
6.4.5 Mexico Pasireotide Drugs Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe Pasireotide Drugs Revenue, 2019-2030
6.5.2 By Country - Europe Pasireotide Drugs Sales, 2019-2030
6.5.3 Germany Pasireotide Drugs Market Size, 2019-2030
6.5.4 France Pasireotide Drugs Market Size, 2019-2030
6.5.5 U.K. Pasireotide Drugs Market Size, 2019-2030
6.5.6 Italy Pasireotide Drugs Market Size, 2019-2030
6.5.7 Russia Pasireotide Drugs Market Size, 2019-2030
6.5.8 Nordic Countries Pasireotide Drugs Market Size, 2019-2030
6.5.9 Benelux Pasireotide Drugs Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia Pasireotide Drugs Revenue, 2019-2030
6.6.2 By Region - Asia Pasireotide Drugs Sales, 2019-2030
6.6.3 China Pasireotide Drugs Market Size, 2019-2030
6.6.4 Japan Pasireotide Drugs Market Size, 2019-2030
6.6.5 South Korea Pasireotide Drugs Market Size, 2019-2030
6.6.6 Southeast Asia Pasireotide Drugs Market Size, 2019-2030
6.6.7 India Pasireotide Drugs Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America Pasireotide Drugs Revenue, 2019-2030
6.7.2 By Country - South America Pasireotide Drugs Sales, 2019-2030
6.7.3 Brazil Pasireotide Drugs Market Size, 2019-2030
6.7.4 Argentina Pasireotide Drugs Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Pasireotide Drugs Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa Pasireotide Drugs Sales, 2019-2030
6.8.3 Turkey Pasireotide Drugs Market Size, 2019-2030
6.8.4 Israel Pasireotide Drugs Market Size, 2019-2030
6.8.5 Saudi Arabia Pasireotide Drugs Market Size, 2019-2030
6.8.6 UAE Pasireotide Drugs Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 Recordati Rare Diseases
7.1.1 Recordati Rare Diseases Company Summary
7.1.2 Recordati Rare Diseases Business Overview
7.1.3 Recordati Rare Diseases Pasireotide Drugs Major Product Offerings
7.1.4 Recordati Rare Diseases Pasireotide Drugs Sales and Revenue in Global (2019-2024)
7.1.5 Recordati Rare Diseases Key News & Latest Developments
8 Global Pasireotide Drugs Production Capacity, Analysis
8.1 Global Pasireotide Drugs Production Capacity, 2019-2030
8.2 Pasireotide Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Pasireotide Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Pasireotide Drugs Supply Chain Analysis
10.1 Pasireotide Drugs Industry Value Chain
10.2 Pasireotide Drugs Upstream Market
10.3 Pasireotide Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Pasireotide Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Pasireotide Drugs in Global Market
Table 2. Top Pasireotide Drugs Players in Global Market, Ranking by Revenue (2023)
Table 3. Global Pasireotide Drugs Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global Pasireotide Drugs Revenue Share by Companies, 2019-2024
Table 5. Global Pasireotide Drugs Sales by Companies, (Units), 2019-2024
Table 6. Global Pasireotide Drugs Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers Pasireotide Drugs Price (2019-2024) & (USD/Unit)
Table 8. Global Manufacturers Pasireotide Drugs Product Type
Table 9. List of Global Tier 1 Pasireotide Drugs Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Pasireotide Drugs Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Pasireotide Drugs Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Global Pasireotide Drugs Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global Pasireotide Drugs Revenue (US$, Mn), 2025-2030
Table 14. By Type - Global Pasireotide Drugs Sales (Units), 2019-2024
Table 15. By Type - Global Pasireotide Drugs Sales (Units), 2025-2030
Table 16. By Application ? Global Pasireotide Drugs Revenue, (US$, Mn), 2023 & 2030
Table 17. By Application - Global Pasireotide Drugs Revenue (US$, Mn), 2019-2024
Table 18. By Application - Global Pasireotide Drugs Revenue (US$, Mn), 2025-2030
Table 19. By Application - Global Pasireotide Drugs Sales (Units), 2019-2024
Table 20. By Application - Global Pasireotide Drugs Sales (Units), 2025-2030
Table 21. By Region ? Global Pasireotide Drugs Revenue, (US$, Mn), 2023 VS 2030
Table 22. By Region - Global Pasireotide Drugs Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global Pasireotide Drugs Revenue (US$, Mn), 2025-2030
Table 24. By Region - Global Pasireotide Drugs Sales (Units), 2019-2024
Table 25. By Region - Global Pasireotide Drugs Sales (Units), 2025-2030
Table 26. By Country - North America Pasireotide Drugs Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America Pasireotide Drugs Revenue, (US$, Mn), 2025-2030
Table 28. By Country - North America Pasireotide Drugs Sales, (Units), 2019-2024
Table 29. By Country - North America Pasireotide Drugs Sales, (Units), 2025-2030
Table 30. By Country - Europe Pasireotide Drugs Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe Pasireotide Drugs Revenue, (US$, Mn), 2025-2030
Table 32. By Country - Europe Pasireotide Drugs Sales, (Units), 2019-2024
Table 33. By Country - Europe Pasireotide Drugs Sales, (Units), 2025-2030
Table 34. By Region - Asia Pasireotide Drugs Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia Pasireotide Drugs Revenue, (US$, Mn), 2025-2030
Table 36. By Region - Asia Pasireotide Drugs Sales, (Units), 2019-2024
Table 37. By Region - Asia Pasireotide Drugs Sales, (Units), 2025-2030
Table 38. By Country - South America Pasireotide Drugs Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America Pasireotide Drugs Revenue, (US$, Mn), 2025-2030
Table 40. By Country - South America Pasireotide Drugs Sales, (Units), 2019-2024
Table 41. By Country - South America Pasireotide Drugs Sales, (Units), 2025-2030
Table 42. By Country - Middle East & Africa Pasireotide Drugs Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa Pasireotide Drugs Revenue, (US$, Mn), 2025-2030
Table 44. By Country - Middle East & Africa Pasireotide Drugs Sales, (Units), 2019-2024
Table 45. By Country - Middle East & Africa Pasireotide Drugs Sales, (Units), 2025-2030
Table 46. Recordati Rare Diseases Company Summary
Table 47. Recordati Rare Diseases Pasireotide Drugs Product Offerings
Table 48. Recordati Rare Diseases Pasireotide Drugs Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 49. Recordati Rare Diseases Key News & Latest Developments
Table 50. Pasireotide Drugs Production Capacity (Units) of Key Manufacturers in Global Market, 2022-2024 (Units)
Table 51. Global Pasireotide Drugs Capacity Market Share of Key Manufacturers, 2022-2024
Table 52. Global Pasireotide Drugs Production by Region, 2019-2024 (Units)
Table 53. Global Pasireotide Drugs Production by Region, 2025-2030 (Units)
Table 54. Pasireotide Drugs Market Opportunities & Trends in Global Market
Table 55. Pasireotide Drugs Market Drivers in Global Market
Table 56. Pasireotide Drugs Market Restraints in Global Market
Table 57. Pasireotide Drugs Raw Materials
Table 58. Pasireotide Drugs Raw Materials Suppliers in Global Market
Table 59. Typical Pasireotide Drugs Downstream
Table 60. Pasireotide Drugs Downstream Clients in Global Market
Table 61. Pasireotide Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Pasireotide Drugs Segment by Type in 2023
Figure 2. Pasireotide Drugs Segment by Application in 2023
Figure 3. Global Pasireotide Drugs Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Pasireotide Drugs Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Pasireotide Drugs Revenue, 2019-2030 (US$, Mn)
Figure 7. Pasireotide Drugs Sales in Global Market: 2019-2030 (Units)
Figure 8. The Top 3 and 5 Players Market Share by Pasireotide Drugs Revenue in 2023
Figure 9. By Type - Global Pasireotide Drugs Revenue, (US$, Mn), 2023 & 2030
Figure 10. By Type - Global Pasireotide Drugs Revenue Market Share, 2019-2030
Figure 11. By Type - Global Pasireotide Drugs Sales Market Share, 2019-2030
Figure 12. By Type - Global Pasireotide Drugs Price (USD/Unit), 2019-2030
Figure 13. By Application - Global Pasireotide Drugs Revenue, (US$, Mn), 2023 & 2030
Figure 14. By Application - Global Pasireotide Drugs Revenue Market Share, 2019-2030
Figure 15. By Application - Global Pasireotide Drugs Sales Market Share, 2019-2030
Figure 16. By Application - Global Pasireotide Drugs Price (USD/Unit), 2019-2030
Figure 17. By Region - Global Pasireotide Drugs Revenue, (US$, Mn), 2023 & 2030
Figure 18. By Region - Global Pasireotide Drugs Revenue Market Share, 2019 VS 2023 VS 2030
Figure 19. By Region - Global Pasireotide Drugs Revenue Market Share, 2019-2030
Figure 20. By Region - Global Pasireotide Drugs Sales Market Share, 2019-2030
Figure 21. By Country - North America Pasireotide Drugs Revenue Market Share, 2019-2030
Figure 22. By Country - North America Pasireotide Drugs Sales Market Share, 2019-2030
Figure 23. US Pasireotide Drugs Revenue, (US$, Mn), 2019-2030
Figure 24. Canada Pasireotide Drugs Revenue, (US$, Mn), 2019-2030
Figure 25. Mexico Pasireotide Drugs Revenue, (US$, Mn), 2019-2030
Figure 26. By Country - Europe Pasireotide Drugs Revenue Market Share, 2019-2030
Figure 27. By Country - Europe Pasireotide Drugs Sales Market Share, 2019-2030
Figure 28. Germany Pasireotide Drugs Revenue, (US$, Mn), 2019-2030
Figure 29. France Pasireotide Drugs Revenue, (US$, Mn), 2019-2030
Figure 30. U.K. Pasireotide Drugs Revenue, (US$, Mn), 2019-2030
Figure 31. Italy Pasireotide Drugs Revenue, (US$, Mn), 2019-2030
Figure 32. Russia Pasireotide Drugs Revenue, (US$, Mn), 2019-2030
Figure 33. Nordic Countries Pasireotide Drugs Revenue, (US$, Mn), 2019-2030
Figure 34. Benelux Pasireotide Drugs Revenue, (US$, Mn), 2019-2030
Figure 35. By Region - Asia Pasireotide Drugs Revenue Market Share, 2019-2030
Figure 36. By Region - Asia Pasireotide Drugs Sales Market Share, 2019-2030
Figure 37. China Pasireotide Drugs Revenue, (US$, Mn), 2019-2030
Figure 38. Japan Pasireotide Drugs Revenue, (US$, Mn), 2019-2030
Figure 39. South Korea Pasireotide Drugs Revenue, (US$, Mn), 2019-2030
Figure 40. Southeast Asia Pasireotide Drugs Revenue, (US$, Mn), 2019-2030
Figure 41. India Pasireotide Drugs Revenue, (US$, Mn), 2019-2030
Figure 42. By Country - South America Pasireotide Drugs Revenue Market Share, 2019-2030
Figure 43. By Country - South America Pasireotide Drugs Sales Market Share, 2019-2030
Figure 44. Brazil Pasireotide Drugs Revenue, (US$, Mn), 2019-2030
Figure 45. Argentina Pasireotide Drugs Revenue, (US$, Mn), 2019-2030
Figure 46. By Country - Middle East & Africa Pasireotide Drugs Revenue Market Share, 2019-2030
Figure 47. By Country - Middle East & Africa Pasireotide Drugs Sales Market Share, 2019-2030
Figure 48. Turkey Pasireotide Drugs Revenue, (US$, Mn), 2019-2030
Figure 49. Israel Pasireotide Drugs Revenue, (US$, Mn), 2019-2030
Figure 50. Saudi Arabia Pasireotide Drugs Revenue, (US$, Mn), 2019-2030
Figure 51. UAE Pasireotide Drugs Revenue, (US$, Mn), 2019-2030
Figure 52. Global Pasireotide Drugs Production Capacity (Units), 2019-2030
Figure 53. The Percentage of Production Pasireotide Drugs by Region, 2023 VS 2030
Figure 54. Pasireotide Drugs Industry Value Chain
Figure 55. Marketing Channels
